Valuation: TELCON RF PHARMACEUTICAL. Inc.

Market Cap 1.17TCr 86.98L 78.04L 72.15L 65.34L 1.22Cr 83Cr 1.24Cr 8.63Cr 3.44Cr 43Cr 3.26Cr 3.2Cr 137.61Cr P/E 2024
-2.64x
P/E 2025 -3.84x
Enterprise Value 1.38TCr 1.03Cr 92.34L 85.37L 77.32L 1.44Cr 98Cr 1.46Cr 10Cr 4.07Cr 51Cr 3.86Cr 3.78Cr 162.84Cr EV / Sales 2024
3.07x
EV / Sales 2025 1.51x
Free-Float
83.87%
Yield 2024 *
-
Yield 2025 -
14/07 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 4.999999736 billion in funding from Telcon Holdings Co., Ltd. CI
06/07 TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 4.999999736 billion in funding from Telcon Holdings Co., Ltd. CI
03/07 KPM TECH Co., Ltd. announced that it expects to receive KRW 22.499999595 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
17/04 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 3 billion in funding from Nuon Co., Ltd. CI
17/04 KPM TECH Co., Ltd. announced that it has received KRW 7.9999997 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
07/04 TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 3 billion in funding from Nuon Co., Ltd. CI
07/04 KPM TECH Co., Ltd. announced that it expects to receive KRW 7.999999854 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
23/25/23 Telcon Rf Pharmaceutical To Conduct Capital Increase Of 28 Billion Won RE
22/25/22 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 12 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd. CI
21/25/21 TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 12 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd. CI
18/25/18 TELCON RF PHARMACEUTICAL. Inc. Auditor Raises 'Going Concern' Doubt CI
23/24/23 ABION Inc. announced that it has received KRW 8.0011152 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
12/24/12 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 2.5 billion in funding CI
1 day-3.26%
1 week-5.02%
Current month-4.15%
1 month-4.81%
3 months+1.71%
6 months-68.20%
Current year-77.32%
1 week 1,990
Extreme 1990
2,190
1 month 1,990
Extreme 1990
2,470
Current year 1,700
Extreme 1700
11,500
1 year 1,700
Extreme 1700
13,200
3 years 1,700
Extreme 1700
44,333.33
5 years 1,700
Extreme 1700
1,24,333.33
10 years 1,700
Extreme 1700
6,48,333.33
Manager TitleAgeSince
Chief Executive Officer 56 01/11/2017
Director of Finance/CFO 50 28/03/2019
Corporate Officer/Principal 54 30/03/2022
Director TitleAgeSince
Director/Board Member 50 28/03/2019
Director/Board Member 49 28/03/2019
Director/Board Member 56 01/11/2017
Date Insider Type Main position Quantity % Market Cap. Importance
20/08/25 ExerciceCompany 11,11,280 4.8639%
20/08/25 ConversionCompany 11,11,280 4.8639%
30/07/25 FreeCompany 22,22,560 18.4828%
Change 5-day change 1-year change 3-year change Capi.($)
-3.26%-5.02%-79.69%-91.02% 91.09L
-0.98%+2.82%+51.87%+113.86% 44TCr
-0.15%+1.30%+19.10%+325.04% 24TCr
+5.92%-0.27%-33.15%+245.70% 14TCr
+10.28%-1.79%+25.02%+896.33% 10TCr
-0.05%+3.40%+9.81%+75.00% 8TCr
+5.52%+7.44%+360.68%+2,196.93% 7.85TCr
-5.82%-6.40%+9.84%+169.07% 5.58TCr
+2.14%+0.88%+50.51%+164.86% 5.07TCr
-0.29%+4.05%+0.74%-4.87% 4.71TCr
Average +2.26%+2.82%+41.48%+409.09% 12.25TCr
Weighted average by Cap. +1.99%+3.77%+46.95%+364.98%

Financials

2024 2025
Net sales 3.79TCr 2.82Cr 2.53Cr 2.34Cr 2.12Cr 3.95Cr 268.27Cr 4Cr 28Cr 11Cr 140.38Cr 11Cr 10Cr 445.66Cr 4.32TCr 3.21Cr 2.88Cr 2.66Cr 2.41Cr 4.51Cr 305.8Cr 4.56Cr 32Cr 13Cr 160.02Cr 12Cr 12Cr 508Cr
Net income -2.63TCr -1.96Cr -1.76Cr -1.62Cr -1.47Cr -2.75Cr -186.47Cr -2.78Cr -19Cr -7.73Cr -98Cr -7.35Cr -7.19Cr -309.78Cr -1.15TCr -85.22L -76.46L -70.69L -64.02L -1.2Cr -81Cr -1.21Cr -8.45Cr -3.37Cr -42Cr -3.2Cr -3.13Cr -134.83Cr
Net Debt 4.57TCr 3.4Cr 3.05Cr 2.82Cr 2.55Cr 4.77Cr 323.45Cr 4.82Cr 34Cr 13Cr 169.26Cr 13Cr 12Cr 537.33Cr 214.34Cr 15.94L 14.31L 13.23L 11.98L 22.38L 15Cr 22.65L 1.58Cr 62.99L 7.95Cr 59.83L 58.57L 25Cr
Projected Income Statement - Annual - TELCON RF PHARMACEUTICAL. Inc.
Logo TELCON RF PHARMACEUTICAL. Inc.
TELCON RF PHARMACEUTICAL. Inc., formerly TELCON.Inc, is a Korea-based company principally engaged in the manufacture and distribution of connectors and cable assemblies. The Company’s products mainly consist of radio frequency (RF) connectors, RF cables, couplers, dividers, arrestors, terminations, adapters, and other cable assemblies, which are used for wireless communication equipment.
Employees
126
Date Price Change Volume
28/26/28 ₩2,080.00 -3.26% 14,633
27/26/27 ₩2,150.00 +4.12% 28,822
26/26/26 ₩2,065.00 -1.20% 35,340
23/26/23 ₩2,090.00 -1.65% 8,677
22/26/22 ₩2,125.00 -0.93% 5,052
  1. Stock Market
  2. Stocks
  3. A200230 Stock